[1]
„Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study“, AJBR, Bd. 22, Nr. 3, S. 347–352, Dez. 2019, Zugegriffen: 6. Juni 2026. [Online]. Verfügbar unter: https://ojshostng.com/index.php/ajbr/article/view/1335